CIK: 1761366 - Address: C/O Viking Therapeutics, Inc., 9920 Pacific Heights Blvd, Suite 350, San Diego, CA 92121
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/8/25 19:05
3/31/25
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRouan Sarah KathrynCADP.a3024.1501New1D
4/2/25 18:29
3/31/25
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRouan Sarah KathrynCADP3024.1501New1D
10/25/24 19:28
10/25/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRouan Sarah KathrynCADM.d544.880110D
10/25/24 19:28
10/25/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRouan Sarah KathrynCADS.d-89080.890-11-1000D
2/8/24 19:38
2/8/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRouan Sarah KathrynCADM.d2088.320250D
2/8/24 19:38
2/8/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRouan Sarah KathrynCADS.d-70128.050-25-1000D
1/19/24 20:35
1/19/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRouan Sarah KathrynCADM.d2508.320300D
1/19/24 20:35
1/19/24
VKTXViking Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsRouan Sarah KathrynCADS.d-69223.050-30-1000D
5/21/19 16:10
5/17/19
NAVBNavidea Biopharmaceuticals, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticRouan Sarah KathrynOHDP51.4603678D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact